| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |